PolyBio
Media Enriched with Newly Synthesized Antibodies (MENSA) is a novel detection assay for persistent infections currently integrated into several PolyBio-supported Long COVID clinical trials. By isolating plasmablasts from blood samples—cells that form new antibodies in response